Review



tfap2a construct  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc tfap2a construct
    <t>TFAP2A</t> is functionally associated with TP63-binding sites. ( A ) Effect on the IRF6 enhancer activity of the addition of exogenous TP63 in H1299 cells as measured by luciferase activity. All luciferase graphs represent the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05. ( B ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the IRF6 enhancer region in H1299 cells. ( C ) Western blot analysis of exogenous TP63 and TFAP2A expression in H1299 cells. ( D ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the PVRL1 enhancer region in H1299 cells. ( E ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2, PVRL1 and PDGFC associated binding sites, expressed as fold enrichment compared to a negative control region within the same ChIP. Data represent the mean of two independent biological replicates. ( F ) Western blot validation of TP63 and TFAP2A depletion in HFKs used in recruitment ChIPs. ( G ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2 and PVRL1 associated binding sites in HFKs depleted for TP63 or TFAP2A compared to scrambled control. Results calculated as fold enrichment compared to a negative control region within the same ChIP and normalized to scrambled control to compare between antibodies and experiments. Data represent the mean of two independent biological replicates. ( H ) Quantitative ChIP-PCR of second negative control binding site (BCL2 upstream) in HFKs depleted for TP63 or TFAP2A expressed as fold change compared to scrambled control. Data represent the mean of two independent biological replicates. ( I ) Quantitative RT-PCR quantification of expression of CL/P associated genes in TFAP2A-depleted human foreskin keratinocytes compared to scrambled control. Graph represents the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05, ** P < 0.01.
    Tfap2a Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tfap2a+construct/SP+(RSV)+AP-2+(Plasmid+%2312100)/pmc03424553-92-1-6
    Average 93 stars, based on 10 article reviews
    tfap2a construct - by Bioz Stars, 2026-10
    93/100 stars

    Images

    1) Product Images from "Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation"

    Article Title: Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation

    Journal: Nucleic Acids Research

    doi: 10.1093/nar/gks389

    TFAP2A is functionally associated with TP63-binding sites. ( A ) Effect on the IRF6 enhancer activity of the addition of exogenous TP63 in H1299 cells as measured by luciferase activity. All luciferase graphs represent the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05. ( B ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the IRF6 enhancer region in H1299 cells. ( C ) Western blot analysis of exogenous TP63 and TFAP2A expression in H1299 cells. ( D ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the PVRL1 enhancer region in H1299 cells. ( E ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2, PVRL1 and PDGFC associated binding sites, expressed as fold enrichment compared to a negative control region within the same ChIP. Data represent the mean of two independent biological replicates. ( F ) Western blot validation of TP63 and TFAP2A depletion in HFKs used in recruitment ChIPs. ( G ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2 and PVRL1 associated binding sites in HFKs depleted for TP63 or TFAP2A compared to scrambled control. Results calculated as fold enrichment compared to a negative control region within the same ChIP and normalized to scrambled control to compare between antibodies and experiments. Data represent the mean of two independent biological replicates. ( H ) Quantitative ChIP-PCR of second negative control binding site (BCL2 upstream) in HFKs depleted for TP63 or TFAP2A expressed as fold change compared to scrambled control. Data represent the mean of two independent biological replicates. ( I ) Quantitative RT-PCR quantification of expression of CL/P associated genes in TFAP2A-depleted human foreskin keratinocytes compared to scrambled control. Graph represents the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05, ** P < 0.01.
    Figure Legend Snippet: TFAP2A is functionally associated with TP63-binding sites. ( A ) Effect on the IRF6 enhancer activity of the addition of exogenous TP63 in H1299 cells as measured by luciferase activity. All luciferase graphs represent the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05. ( B ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the IRF6 enhancer region in H1299 cells. ( C ) Western blot analysis of exogenous TP63 and TFAP2A expression in H1299 cells. ( D ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the PVRL1 enhancer region in H1299 cells. ( E ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2, PVRL1 and PDGFC associated binding sites, expressed as fold enrichment compared to a negative control region within the same ChIP. Data represent the mean of two independent biological replicates. ( F ) Western blot validation of TP63 and TFAP2A depletion in HFKs used in recruitment ChIPs. ( G ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2 and PVRL1 associated binding sites in HFKs depleted for TP63 or TFAP2A compared to scrambled control. Results calculated as fold enrichment compared to a negative control region within the same ChIP and normalized to scrambled control to compare between antibodies and experiments. Data represent the mean of two independent biological replicates. ( H ) Quantitative ChIP-PCR of second negative control binding site (BCL2 upstream) in HFKs depleted for TP63 or TFAP2A expressed as fold change compared to scrambled control. Data represent the mean of two independent biological replicates. ( I ) Quantitative RT-PCR quantification of expression of CL/P associated genes in TFAP2A-depleted human foreskin keratinocytes compared to scrambled control. Graph represents the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05, ** P < 0.01.

    Techniques Used: Binding Assay, Activity Assay, Luciferase, Activation Assay, Western Blot, Expressing, Negative Control, Biomarker Discovery, Control, Quantitative RT-PCR

    Identification of TFAP2A as a potential TP63 co-factor. ( A ) Table of results from transcription factor motif enrichment analysis of 7574 TP63-binding sites. ( B ) Cumulative frequency distribution plots comparing distance of predicted TFAP2A sites and TP63-binding motifs from the centre of TP63-binding sites/peaks. ( C ) Comparison of localization of TP63-binding sites with or without predicted AP-2 sites. ( D and E ) Quantitative PCR ChIP validation of TP63 (D) and TFAP2A (E) binding to TP63 sites associated with CL/P genes (data represent the mean of three biological replicates expressed as % input ± SEM). ( F ) Semi-quantitative PCR results for sequential re-ChIP assay for TP63 and TFAP2A for the IRF6 , FGFR2, TGFB1 and PVRL1 associated TP63-binding sites, showing both factors co-ChIP.
    Figure Legend Snippet: Identification of TFAP2A as a potential TP63 co-factor. ( A ) Table of results from transcription factor motif enrichment analysis of 7574 TP63-binding sites. ( B ) Cumulative frequency distribution plots comparing distance of predicted TFAP2A sites and TP63-binding motifs from the centre of TP63-binding sites/peaks. ( C ) Comparison of localization of TP63-binding sites with or without predicted AP-2 sites. ( D and E ) Quantitative PCR ChIP validation of TP63 (D) and TFAP2A (E) binding to TP63 sites associated with CL/P genes (data represent the mean of three biological replicates expressed as % input ± SEM). ( F ) Semi-quantitative PCR results for sequential re-ChIP assay for TP63 and TFAP2A for the IRF6 , FGFR2, TGFB1 and PVRL1 associated TP63-binding sites, showing both factors co-ChIP.

    Techniques Used: Binding Assay, Comparison, Real-time Polymerase Chain Reaction, Biomarker Discovery

    TFAP2C interacts with a subset of TP63-binding sites. ( A ) Quantitative PCR estimation of TFAP2A and TFAP2C mRNA copy number in cycling HFKs. Data represent the mean of three independent biological replicates ± SEM. ( B ) Quantitative PCR ChIP validation comparing TFAP2A (3B5) and TFAP2C (H77) interaction with a subset of TP63-binding regions associated with CL/P genes. Data represent the mean of three biological replicates expressed as % input ± SEM). ( C and D ) Luciferase assay measuring the effect of the addition of TFAP2A or TFAP2C to six TP63 isoforms on activation of the IRF6 (C) or PVRL1 (D) enhancer region in H1299 cells. ( E ) Luciferase assay measuring the effect of the addition of TFAP2A or TFAP2C on TP63-mediated activation of the IRF6 enhancer region in primary human foreskin keratinocytes (HFKs). Luciferase graphs represent the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05, ** P < 0.01.
    Figure Legend Snippet: TFAP2C interacts with a subset of TP63-binding sites. ( A ) Quantitative PCR estimation of TFAP2A and TFAP2C mRNA copy number in cycling HFKs. Data represent the mean of three independent biological replicates ± SEM. ( B ) Quantitative PCR ChIP validation comparing TFAP2A (3B5) and TFAP2C (H77) interaction with a subset of TP63-binding regions associated with CL/P genes. Data represent the mean of three biological replicates expressed as % input ± SEM). ( C and D ) Luciferase assay measuring the effect of the addition of TFAP2A or TFAP2C to six TP63 isoforms on activation of the IRF6 (C) or PVRL1 (D) enhancer region in H1299 cells. ( E ) Luciferase assay measuring the effect of the addition of TFAP2A or TFAP2C on TP63-mediated activation of the IRF6 enhancer region in primary human foreskin keratinocytes (HFKs). Luciferase graphs represent the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05, ** P < 0.01.

    Techniques Used: Binding Assay, Real-time Polymerase Chain Reaction, Biomarker Discovery, Luciferase, Activation Assay

    TFAP2A and TFAP2C are required for efficient differentiation of organotypic raft cultures. ( A ) Western blot analysis of TFAP2A, TFAP2C, TP63 and actin loading control of the HFKs transfected with TFAP2A, TFAP2C, TP63 targeting and scrambled control siRNA. ( B ) Sections of organotypic raft cultures generated from TFAP2A-, TFAP2C- or TP63-depleted HFKs stained for haematoxylin & Eosin (H&E) and indirect immunofluorescent staining of early [keratins 1 (KRT1), intermediate (transglutaminase-1 (TGM1)] and late [Filaggrin (FLG)] markers of differentiation (scale bar = 100 µM). ( C ) Number of bromodeoxyuridine (BrDU) incorporating cells in organotypic raft culture assessed by immunofluorescent staining. Graph represents the average number of BrDU-positive cells in the basal epithelial layer from organotypic raft cultures per 1000 µM, expressed as percentage scrambled control (mean ± SE at least 10 counts each of two independent biological replicates).
    Figure Legend Snippet: TFAP2A and TFAP2C are required for efficient differentiation of organotypic raft cultures. ( A ) Western blot analysis of TFAP2A, TFAP2C, TP63 and actin loading control of the HFKs transfected with TFAP2A, TFAP2C, TP63 targeting and scrambled control siRNA. ( B ) Sections of organotypic raft cultures generated from TFAP2A-, TFAP2C- or TP63-depleted HFKs stained for haematoxylin & Eosin (H&E) and indirect immunofluorescent staining of early [keratins 1 (KRT1), intermediate (transglutaminase-1 (TGM1)] and late [Filaggrin (FLG)] markers of differentiation (scale bar = 100 µM). ( C ) Number of bromodeoxyuridine (BrDU) incorporating cells in organotypic raft culture assessed by immunofluorescent staining. Graph represents the average number of BrDU-positive cells in the basal epithelial layer from organotypic raft cultures per 1000 µM, expressed as percentage scrambled control (mean ± SE at least 10 counts each of two independent biological replicates).

    Techniques Used: Western Blot, Control, Transfection, Generated, Staining

    Related Articles

    Plasmid Preparation:

    Article Title: Temporally resolved early bone morphogenetic protein-driven transcriptional cascade during human amnion specification
    Article Snippet: We thank K Woltjen (Kyoto University) for the piggyBac DOX- inducible vector (PB- TA- ERN, Addgene#80474), A Brivanlou (Rockefeller University) for ePB transposase, as well as Robert Tjian Sekulovski et al. eLife 2023;12:RP89367. .. DOI: https://doi.org/10.7554/eLife.89367 22 of 26 (University of California – Berkley) for human TFAP2A plasmid (SP (RSV) AP- 2, Addgene #12100). .. We thank Michaela Patterson, Matthew Veldman, and Deborah Gumucio for their insightful comments to the manuscript, as well as Versiti Blood Research Institute Molecular Biology Core Lab and the DNA Services laboratory of the Roy J Carver Biotechnology Center at the University of Illinois at Urbana- Champaign for sequence services.

    Article Title: AP2 suppresses osteoblast differentiation and mineralization through down-regulation of Frizzled-1
    Article Snippet: *Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A. †Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, U.S.A. ‡Program in Personalized and Genomic Medicine and Department of Medicine, Division of Endocrinology, Diabetes and Nutrition, School of Medicine, University of Maryland, Baltimore, MD, U.S.A. §Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, U.S.A.

    Article Title: Silencing of CHD5 Gene by Promoter Methylation in Leukemia
    Article Snippet: .. Twenty-four hours after seeding, medium was changed and cells were co-transfected with pGL4.10 vector or one of the recombinant pGL4.10 vectors and pGL4.74 (Promega), or co-transfected with pGL4.74 vector, expression vector for human AP-2 (Addgene Plasmid 12100) and pGL4.1-CHD5-P-CR or pGL4.10. ..

    Article Title: Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: role of AP-2α and Sp1.
    Article Snippet: Contents lists available at ScienceDirect Cellular Signalling j ourna l homepage: www.e lsev ie r .com/ locate /ce l l s ig Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: Role of AP-2α and Sp1 SWei Sunny Hahn a,⁎, Qing Tang a, Fang Zheng a, Shunyu Zhao a, Jingjing Wu a, Jianping Chen b a Laboratory of Tumor Molecular Biology and Targeted Therapies, University of Guangzhou Traditional Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong Province 510120, China b School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, 10 Sassoon Road, 00852, Hong Kong, China ⁎ Corresponding author at: Laboratory of Tumor Mo Therapies, University of Guangzhou Traditional Chinese Research Building, Neihuan West Road No. 55, Un Guangzhou, Guangdong Province 510006, China.. Tel.. : +8 E-mail address: swhan2010@live.com (S.W.S.

    Article Title: Nicotine induces EP4 receptor expression in lung carcinoma cells by acting on AP-2α: The intersection between cholinergic and prostanoid signaling
    Article Snippet: .. Cells were transfected with control plasmid (2 μg/well) or with AP-2α expression plasmid (1 μg/well) SP(RSV)AP-2 (#12100) (purchased from Addgene, Inc.; Cambridge, MA) [ ] and treated with or without nicotine (0.5 μM) for an additional 24 h before luciferase activity was determined using the Dual-Luciferase Reporter kit (Promega). ..

    Construct:

    Article Title: Temporally resolved early bone morphogenetic protein-driven transcriptional cascade during human amnion specification
    Article Snippet: .. The TFAP2A gRNA targeted site of human TFAP2A construct (gift of Robert Tjian, Addgene #12100, ) was mutated using Q5 site directed mutagenesis kit (NEB, primers: SP (RSV) AP2 (hTFAP2A)-CRISPR RES-fw and SP (RSV) AP2 (hTFAP2A)-CRISPR RES-rv). .. This CRISPR resistant human TFAP2A construct was then PCR amplified (using primers: Clo-dTOPO-hTFAP2A-CRISPR res-fw v2 and Clo-dTOPO-hTFAP2A-CRISPR res-rv v2, HA tagging at C-terminus), which was then cloned into pENTR-dTOPO (Thermo) for Gateway cloning into PB-TA-ERN (Knut Woltjen, Addgene #80474, ) to generate PB-TA-ERN-hTFAP2A(CR)-HA.

    Article Title: Temporally resolved early bone morphogenetic protein-driven transcriptional cascade during human amnion specification
    Article Snippet: .. The TFAP2A gRNA targeted site of human TFAP2A construct (gift of Robert Tjian, Addgene #12100, Williams and Tjian, 1991) was mutated using Q5 site directed mutagenesis kit (NEB, primers: SP (RSV) AP2 (hTFAP2A)- CRISPR RES- fw and SP (RSV) AP2 (hTFAP2A)- CRISPR RES- rv). .. This CRISPR resistant human TFAP2A construct was then PCR amplified (using primers: Clo- dTOPOhTFAP2A- CRISPR res- fw v2 and Clo- dTOPO- hTFAP2A- CRISPR res- rv v2, HA tagging at C- terminus), which was then cloned into pENTR- dTOPO (Thermo) for Gateway cloning into PB- TA- ERN (Knut Woltjen, Addgene #80474, Kim et al., 2016) to generate PB- TA- ERN- hTFAP2A(CR)- HA.

    Mutagenesis:

    Article Title: Temporally resolved early bone morphogenetic protein-driven transcriptional cascade during human amnion specification
    Article Snippet: .. The TFAP2A gRNA targeted site of human TFAP2A construct (gift of Robert Tjian, Addgene #12100, ) was mutated using Q5 site directed mutagenesis kit (NEB, primers: SP (RSV) AP2 (hTFAP2A)-CRISPR RES-fw and SP (RSV) AP2 (hTFAP2A)-CRISPR RES-rv). .. This CRISPR resistant human TFAP2A construct was then PCR amplified (using primers: Clo-dTOPO-hTFAP2A-CRISPR res-fw v2 and Clo-dTOPO-hTFAP2A-CRISPR res-rv v2, HA tagging at C-terminus), which was then cloned into pENTR-dTOPO (Thermo) for Gateway cloning into PB-TA-ERN (Knut Woltjen, Addgene #80474, ) to generate PB-TA-ERN-hTFAP2A(CR)-HA.

    Article Title: Temporally resolved early bone morphogenetic protein-driven transcriptional cascade during human amnion specification
    Article Snippet: .. The TFAP2A gRNA targeted site of human TFAP2A construct (gift of Robert Tjian, Addgene #12100, Williams and Tjian, 1991) was mutated using Q5 site directed mutagenesis kit (NEB, primers: SP (RSV) AP2 (hTFAP2A)- CRISPR RES- fw and SP (RSV) AP2 (hTFAP2A)- CRISPR RES- rv). .. This CRISPR resistant human TFAP2A construct was then PCR amplified (using primers: Clo- dTOPOhTFAP2A- CRISPR res- fw v2 and Clo- dTOPO- hTFAP2A- CRISPR res- rv v2, HA tagging at C- terminus), which was then cloned into pENTR- dTOPO (Thermo) for Gateway cloning into PB- TA- ERN (Knut Woltjen, Addgene #80474, Kim et al., 2016) to generate PB- TA- ERN- hTFAP2A(CR)- HA.

    Expressing:

    Article Title: AP2 suppresses osteoblast differentiation and mineralization through down-regulation of Frizzled-1
    Article Snippet: *Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A. †Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, U.S.A. ‡Program in Personalized and Genomic Medicine and Department of Medicine, Division of Endocrinology, Diabetes and Nutrition, School of Medicine, University of Maryland, Baltimore, MD, U.S.A. §Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, U.S.A.

    Article Title: Silencing of CHD5 Gene by Promoter Methylation in Leukemia
    Article Snippet: .. Twenty-four hours after seeding, medium was changed and cells were co-transfected with pGL4.10 vector or one of the recombinant pGL4.10 vectors and pGL4.74 (Promega), or co-transfected with pGL4.74 vector, expression vector for human AP-2 (Addgene Plasmid 12100) and pGL4.1-CHD5-P-CR or pGL4.10. ..

    Article Title: Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: role of AP-2α and Sp1.
    Article Snippet: Contents lists available at ScienceDirect Cellular Signalling j ourna l homepage: www.e lsev ie r .com/ locate /ce l l s ig Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: Role of AP-2α and Sp1 SWei Sunny Hahn a,⁎, Qing Tang a, Fang Zheng a, Shunyu Zhao a, Jingjing Wu a, Jianping Chen b a Laboratory of Tumor Molecular Biology and Targeted Therapies, University of Guangzhou Traditional Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong Province 510120, China b School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, 10 Sassoon Road, 00852, Hong Kong, China ⁎ Corresponding author at: Laboratory of Tumor Mo Therapies, University of Guangzhou Traditional Chinese Research Building, Neihuan West Road No. 55, Un Guangzhou, Guangdong Province 510006, China.. Tel.. : +8 E-mail address: swhan2010@live.com (S.W.S.

    Article Title: Nicotine induces EP4 receptor expression in lung carcinoma cells by acting on AP-2α: The intersection between cholinergic and prostanoid signaling
    Article Snippet: .. Cells were transfected with control plasmid (2 μg/well) or with AP-2α expression plasmid (1 μg/well) SP(RSV)AP-2 (#12100) (purchased from Addgene, Inc.; Cambridge, MA) [ ] and treated with or without nicotine (0.5 μM) for an additional 24 h before luciferase activity was determined using the Dual-Luciferase Reporter kit (Promega). ..

    CRISPR:

    Article Title: Temporally resolved early bone morphogenetic protein-driven transcriptional cascade during human amnion specification
    Article Snippet: .. The TFAP2A gRNA targeted site of human TFAP2A construct (gift of Robert Tjian, Addgene #12100, Williams and Tjian, 1991) was mutated using Q5 site directed mutagenesis kit (NEB, primers: SP (RSV) AP2 (hTFAP2A)- CRISPR RES- fw and SP (RSV) AP2 (hTFAP2A)- CRISPR RES- rv). .. This CRISPR resistant human TFAP2A construct was then PCR amplified (using primers: Clo- dTOPOhTFAP2A- CRISPR res- fw v2 and Clo- dTOPO- hTFAP2A- CRISPR res- rv v2, HA tagging at C- terminus), which was then cloned into pENTR- dTOPO (Thermo) for Gateway cloning into PB- TA- ERN (Knut Woltjen, Addgene #80474, Kim et al., 2016) to generate PB- TA- ERN- hTFAP2A(CR)- HA.

    Recombinant:

    Article Title: Silencing of CHD5 Gene by Promoter Methylation in Leukemia
    Article Snippet: .. Twenty-four hours after seeding, medium was changed and cells were co-transfected with pGL4.10 vector or one of the recombinant pGL4.10 vectors and pGL4.74 (Promega), or co-transfected with pGL4.74 vector, expression vector for human AP-2 (Addgene Plasmid 12100) and pGL4.1-CHD5-P-CR or pGL4.10. ..

    Transfection:

    Article Title: Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: role of AP-2α and Sp1.
    Article Snippet: Contents lists available at ScienceDirect Cellular Signalling j ourna l homepage: www.e lsev ie r .com/ locate /ce l l s ig Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: Role of AP-2α and Sp1 SWei Sunny Hahn a,⁎, Qing Tang a, Fang Zheng a, Shunyu Zhao a, Jingjing Wu a, Jianping Chen b a Laboratory of Tumor Molecular Biology and Targeted Therapies, University of Guangzhou Traditional Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong Province 510120, China b School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, 10 Sassoon Road, 00852, Hong Kong, China ⁎ Corresponding author at: Laboratory of Tumor Mo Therapies, University of Guangzhou Traditional Chinese Research Building, Neihuan West Road No. 55, Un Guangzhou, Guangdong Province 510006, China.. Tel.. : +8 E-mail address: swhan2010@live.com (S.W.S.

    Article Title: Nicotine induces EP4 receptor expression in lung carcinoma cells by acting on AP-2α: The intersection between cholinergic and prostanoid signaling
    Article Snippet: .. Cells were transfected with control plasmid (2 μg/well) or with AP-2α expression plasmid (1 μg/well) SP(RSV)AP-2 (#12100) (purchased from Addgene, Inc.; Cambridge, MA) [ ] and treated with or without nicotine (0.5 μM) for an additional 24 h before luciferase activity was determined using the Dual-Luciferase Reporter kit (Promega). ..

    Control:

    Article Title: Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: role of AP-2α and Sp1.
    Article Snippet: Contents lists available at ScienceDirect Cellular Signalling j ourna l homepage: www.e lsev ie r .com/ locate /ce l l s ig Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: Role of AP-2α and Sp1 SWei Sunny Hahn a,⁎, Qing Tang a, Fang Zheng a, Shunyu Zhao a, Jingjing Wu a, Jianping Chen b a Laboratory of Tumor Molecular Biology and Targeted Therapies, University of Guangzhou Traditional Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong Province 510120, China b School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, 10 Sassoon Road, 00852, Hong Kong, China ⁎ Corresponding author at: Laboratory of Tumor Mo Therapies, University of Guangzhou Traditional Chinese Research Building, Neihuan West Road No. 55, Un Guangzhou, Guangdong Province 510006, China.. Tel.. : +8 E-mail address: swhan2010@live.com (S.W.S.

    Article Title: Nicotine induces EP4 receptor expression in lung carcinoma cells by acting on AP-2α: The intersection between cholinergic and prostanoid signaling
    Article Snippet: .. Cells were transfected with control plasmid (2 μg/well) or with AP-2α expression plasmid (1 μg/well) SP(RSV)AP-2 (#12100) (purchased from Addgene, Inc.; Cambridge, MA) [ ] and treated with or without nicotine (0.5 μM) for an additional 24 h before luciferase activity was determined using the Dual-Luciferase Reporter kit (Promega). ..

    Over Expression:

    Article Title: Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: role of AP-2α and Sp1.
    Article Snippet: Contents lists available at ScienceDirect Cellular Signalling j ourna l homepage: www.e lsev ie r .com/ locate /ce l l s ig Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: Role of AP-2α and Sp1 SWei Sunny Hahn a,⁎, Qing Tang a, Fang Zheng a, Shunyu Zhao a, Jingjing Wu a, Jianping Chen b a Laboratory of Tumor Molecular Biology and Targeted Therapies, University of Guangzhou Traditional Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong Province 510120, China b School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, 10 Sassoon Road, 00852, Hong Kong, China ⁎ Corresponding author at: Laboratory of Tumor Mo Therapies, University of Guangzhou Traditional Chinese Research Building, Neihuan West Road No. 55, Un Guangzhou, Guangdong Province 510006, China.. Tel.. : +8 E-mail address: swhan2010@live.com (S.W.S.

    Luciferase:

    Article Title: Nicotine induces EP4 receptor expression in lung carcinoma cells by acting on AP-2α: The intersection between cholinergic and prostanoid signaling
    Article Snippet: .. Cells were transfected with control plasmid (2 μg/well) or with AP-2α expression plasmid (1 μg/well) SP(RSV)AP-2 (#12100) (purchased from Addgene, Inc.; Cambridge, MA) [ ] and treated with or without nicotine (0.5 μM) for an additional 24 h before luciferase activity was determined using the Dual-Luciferase Reporter kit (Promega). ..

    Activity Assay:

    Article Title: Nicotine induces EP4 receptor expression in lung carcinoma cells by acting on AP-2α: The intersection between cholinergic and prostanoid signaling
    Article Snippet: .. Cells were transfected with control plasmid (2 μg/well) or with AP-2α expression plasmid (1 μg/well) SP(RSV)AP-2 (#12100) (purchased from Addgene, Inc.; Cambridge, MA) [ ] and treated with or without nicotine (0.5 μM) for an additional 24 h before luciferase activity was determined using the Dual-Luciferase Reporter kit (Promega). ..



    Similar Products

    93
    Addgene inc human tfap2a construct
    Human Tfap2a Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tfap2a+construct/SP+(RSV)+AP-2+(Plasmid+%2312100)/10__7554_slash_elife__89367__3-273-6-13
    Average 93 stars, based on 1 article reviews
    human tfap2a construct - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Addgene inc tfap2a construct
    <t>TFAP2A</t> is functionally associated with TP63-binding sites. ( A ) Effect on the IRF6 enhancer activity of the addition of exogenous TP63 in H1299 cells as measured by luciferase activity. All luciferase graphs represent the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05. ( B ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the IRF6 enhancer region in H1299 cells. ( C ) Western blot analysis of exogenous TP63 and TFAP2A expression in H1299 cells. ( D ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the PVRL1 enhancer region in H1299 cells. ( E ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2, PVRL1 and PDGFC associated binding sites, expressed as fold enrichment compared to a negative control region within the same ChIP. Data represent the mean of two independent biological replicates. ( F ) Western blot validation of TP63 and TFAP2A depletion in HFKs used in recruitment ChIPs. ( G ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2 and PVRL1 associated binding sites in HFKs depleted for TP63 or TFAP2A compared to scrambled control. Results calculated as fold enrichment compared to a negative control region within the same ChIP and normalized to scrambled control to compare between antibodies and experiments. Data represent the mean of two independent biological replicates. ( H ) Quantitative ChIP-PCR of second negative control binding site (BCL2 upstream) in HFKs depleted for TP63 or TFAP2A expressed as fold change compared to scrambled control. Data represent the mean of two independent biological replicates. ( I ) Quantitative RT-PCR quantification of expression of CL/P associated genes in TFAP2A-depleted human foreskin keratinocytes compared to scrambled control. Graph represents the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05, ** P < 0.01.
    Tfap2a Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tfap2a+construct/SP+(RSV)+AP-2+(Plasmid+%2312100)/pmc03424553-92-1-6
    Average 93 stars, based on 1 article reviews
    tfap2a construct - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    90
    Promega pcdna3-tfap2a construct
    <t>TFAP2A</t> is functionally associated with TP63-binding sites. ( A ) Effect on the IRF6 enhancer activity of the addition of exogenous TP63 in H1299 cells as measured by luciferase activity. All luciferase graphs represent the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05. ( B ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the IRF6 enhancer region in H1299 cells. ( C ) Western blot analysis of exogenous TP63 and TFAP2A expression in H1299 cells. ( D ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the PVRL1 enhancer region in H1299 cells. ( E ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2, PVRL1 and PDGFC associated binding sites, expressed as fold enrichment compared to a negative control region within the same ChIP. Data represent the mean of two independent biological replicates. ( F ) Western blot validation of TP63 and TFAP2A depletion in HFKs used in recruitment ChIPs. ( G ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2 and PVRL1 associated binding sites in HFKs depleted for TP63 or TFAP2A compared to scrambled control. Results calculated as fold enrichment compared to a negative control region within the same ChIP and normalized to scrambled control to compare between antibodies and experiments. Data represent the mean of two independent biological replicates. ( H ) Quantitative ChIP-PCR of second negative control binding site (BCL2 upstream) in HFKs depleted for TP63 or TFAP2A expressed as fold change compared to scrambled control. Data represent the mean of two independent biological replicates. ( I ) Quantitative RT-PCR quantification of expression of CL/P associated genes in TFAP2A-depleted human foreskin keratinocytes compared to scrambled control. Graph represents the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05, ** P < 0.01.
    Pcdna3 Tfap2a Construct, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tfap2a+construct/pcdna3+1/pmc03048049-253-9-17
    Average 90 stars, based on 1 article reviews
    pcdna3-tfap2a construct - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    TFAP2A is functionally associated with TP63-binding sites. ( A ) Effect on the IRF6 enhancer activity of the addition of exogenous TP63 in H1299 cells as measured by luciferase activity. All luciferase graphs represent the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05. ( B ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the IRF6 enhancer region in H1299 cells. ( C ) Western blot analysis of exogenous TP63 and TFAP2A expression in H1299 cells. ( D ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the PVRL1 enhancer region in H1299 cells. ( E ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2, PVRL1 and PDGFC associated binding sites, expressed as fold enrichment compared to a negative control region within the same ChIP. Data represent the mean of two independent biological replicates. ( F ) Western blot validation of TP63 and TFAP2A depletion in HFKs used in recruitment ChIPs. ( G ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2 and PVRL1 associated binding sites in HFKs depleted for TP63 or TFAP2A compared to scrambled control. Results calculated as fold enrichment compared to a negative control region within the same ChIP and normalized to scrambled control to compare between antibodies and experiments. Data represent the mean of two independent biological replicates. ( H ) Quantitative ChIP-PCR of second negative control binding site (BCL2 upstream) in HFKs depleted for TP63 or TFAP2A expressed as fold change compared to scrambled control. Data represent the mean of two independent biological replicates. ( I ) Quantitative RT-PCR quantification of expression of CL/P associated genes in TFAP2A-depleted human foreskin keratinocytes compared to scrambled control. Graph represents the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05, ** P < 0.01.

    Journal: Nucleic Acids Research

    Article Title: Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation

    doi: 10.1093/nar/gks389

    Figure Lengend Snippet: TFAP2A is functionally associated with TP63-binding sites. ( A ) Effect on the IRF6 enhancer activity of the addition of exogenous TP63 in H1299 cells as measured by luciferase activity. All luciferase graphs represent the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05. ( B ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the IRF6 enhancer region in H1299 cells. ( C ) Western blot analysis of exogenous TP63 and TFAP2A expression in H1299 cells. ( D ) Luciferase assay measuring the effect of the addition of increasing amounts of TFAP2A on TP63-mediated activation of the PVRL1 enhancer region in H1299 cells. ( E ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2, PVRL1 and PDGFC associated binding sites, expressed as fold enrichment compared to a negative control region within the same ChIP. Data represent the mean of two independent biological replicates. ( F ) Western blot validation of TP63 and TFAP2A depletion in HFKs used in recruitment ChIPs. ( G ) Quantitative ChIP-PCR comparing TP63 and TFAP2A binding to IRF6, FGFR2, JAG2 and PVRL1 associated binding sites in HFKs depleted for TP63 or TFAP2A compared to scrambled control. Results calculated as fold enrichment compared to a negative control region within the same ChIP and normalized to scrambled control to compare between antibodies and experiments. Data represent the mean of two independent biological replicates. ( H ) Quantitative ChIP-PCR of second negative control binding site (BCL2 upstream) in HFKs depleted for TP63 or TFAP2A expressed as fold change compared to scrambled control. Data represent the mean of two independent biological replicates. ( I ) Quantitative RT-PCR quantification of expression of CL/P associated genes in TFAP2A-depleted human foreskin keratinocytes compared to scrambled control. Graph represents the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05, ** P < 0.01.

    Article Snippet: The TFAP2A construct was obtained from Addgene [plasmid SP(RSV); 12100) ( )], and matched TFAP2A and TFAP2C image clones in pCMVsport6 were obtained from MRC Geneservice (Cambridge).

    Techniques: Binding Assay, Activity Assay, Luciferase, Activation Assay, Western Blot, Expressing, Negative Control, Biomarker Discovery, Control, Quantitative RT-PCR

    Identification of TFAP2A as a potential TP63 co-factor. ( A ) Table of results from transcription factor motif enrichment analysis of 7574 TP63-binding sites. ( B ) Cumulative frequency distribution plots comparing distance of predicted TFAP2A sites and TP63-binding motifs from the centre of TP63-binding sites/peaks. ( C ) Comparison of localization of TP63-binding sites with or without predicted AP-2 sites. ( D and E ) Quantitative PCR ChIP validation of TP63 (D) and TFAP2A (E) binding to TP63 sites associated with CL/P genes (data represent the mean of three biological replicates expressed as % input ± SEM). ( F ) Semi-quantitative PCR results for sequential re-ChIP assay for TP63 and TFAP2A for the IRF6 , FGFR2, TGFB1 and PVRL1 associated TP63-binding sites, showing both factors co-ChIP.

    Journal: Nucleic Acids Research

    Article Title: Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation

    doi: 10.1093/nar/gks389

    Figure Lengend Snippet: Identification of TFAP2A as a potential TP63 co-factor. ( A ) Table of results from transcription factor motif enrichment analysis of 7574 TP63-binding sites. ( B ) Cumulative frequency distribution plots comparing distance of predicted TFAP2A sites and TP63-binding motifs from the centre of TP63-binding sites/peaks. ( C ) Comparison of localization of TP63-binding sites with or without predicted AP-2 sites. ( D and E ) Quantitative PCR ChIP validation of TP63 (D) and TFAP2A (E) binding to TP63 sites associated with CL/P genes (data represent the mean of three biological replicates expressed as % input ± SEM). ( F ) Semi-quantitative PCR results for sequential re-ChIP assay for TP63 and TFAP2A for the IRF6 , FGFR2, TGFB1 and PVRL1 associated TP63-binding sites, showing both factors co-ChIP.

    Article Snippet: The TFAP2A construct was obtained from Addgene [plasmid SP(RSV); 12100) ( )], and matched TFAP2A and TFAP2C image clones in pCMVsport6 were obtained from MRC Geneservice (Cambridge).

    Techniques: Binding Assay, Comparison, Real-time Polymerase Chain Reaction, Biomarker Discovery

    TFAP2C interacts with a subset of TP63-binding sites. ( A ) Quantitative PCR estimation of TFAP2A and TFAP2C mRNA copy number in cycling HFKs. Data represent the mean of three independent biological replicates ± SEM. ( B ) Quantitative PCR ChIP validation comparing TFAP2A (3B5) and TFAP2C (H77) interaction with a subset of TP63-binding regions associated with CL/P genes. Data represent the mean of three biological replicates expressed as % input ± SEM). ( C and D ) Luciferase assay measuring the effect of the addition of TFAP2A or TFAP2C to six TP63 isoforms on activation of the IRF6 (C) or PVRL1 (D) enhancer region in H1299 cells. ( E ) Luciferase assay measuring the effect of the addition of TFAP2A or TFAP2C on TP63-mediated activation of the IRF6 enhancer region in primary human foreskin keratinocytes (HFKs). Luciferase graphs represent the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05, ** P < 0.01.

    Journal: Nucleic Acids Research

    Article Title: Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation

    doi: 10.1093/nar/gks389

    Figure Lengend Snippet: TFAP2C interacts with a subset of TP63-binding sites. ( A ) Quantitative PCR estimation of TFAP2A and TFAP2C mRNA copy number in cycling HFKs. Data represent the mean of three independent biological replicates ± SEM. ( B ) Quantitative PCR ChIP validation comparing TFAP2A (3B5) and TFAP2C (H77) interaction with a subset of TP63-binding regions associated with CL/P genes. Data represent the mean of three biological replicates expressed as % input ± SEM). ( C and D ) Luciferase assay measuring the effect of the addition of TFAP2A or TFAP2C to six TP63 isoforms on activation of the IRF6 (C) or PVRL1 (D) enhancer region in H1299 cells. ( E ) Luciferase assay measuring the effect of the addition of TFAP2A or TFAP2C on TP63-mediated activation of the IRF6 enhancer region in primary human foreskin keratinocytes (HFKs). Luciferase graphs represent the mean fold increase of at least three independent biological ± SEM; Student’s t -test * P < 0.05, ** P < 0.01.

    Article Snippet: The TFAP2A construct was obtained from Addgene [plasmid SP(RSV); 12100) ( )], and matched TFAP2A and TFAP2C image clones in pCMVsport6 were obtained from MRC Geneservice (Cambridge).

    Techniques: Binding Assay, Real-time Polymerase Chain Reaction, Biomarker Discovery, Luciferase, Activation Assay

    TFAP2A and TFAP2C are required for efficient differentiation of organotypic raft cultures. ( A ) Western blot analysis of TFAP2A, TFAP2C, TP63 and actin loading control of the HFKs transfected with TFAP2A, TFAP2C, TP63 targeting and scrambled control siRNA. ( B ) Sections of organotypic raft cultures generated from TFAP2A-, TFAP2C- or TP63-depleted HFKs stained for haematoxylin & Eosin (H&E) and indirect immunofluorescent staining of early [keratins 1 (KRT1), intermediate (transglutaminase-1 (TGM1)] and late [Filaggrin (FLG)] markers of differentiation (scale bar = 100 µM). ( C ) Number of bromodeoxyuridine (BrDU) incorporating cells in organotypic raft culture assessed by immunofluorescent staining. Graph represents the average number of BrDU-positive cells in the basal epithelial layer from organotypic raft cultures per 1000 µM, expressed as percentage scrambled control (mean ± SE at least 10 counts each of two independent biological replicates).

    Journal: Nucleic Acids Research

    Article Title: Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation

    doi: 10.1093/nar/gks389

    Figure Lengend Snippet: TFAP2A and TFAP2C are required for efficient differentiation of organotypic raft cultures. ( A ) Western blot analysis of TFAP2A, TFAP2C, TP63 and actin loading control of the HFKs transfected with TFAP2A, TFAP2C, TP63 targeting and scrambled control siRNA. ( B ) Sections of organotypic raft cultures generated from TFAP2A-, TFAP2C- or TP63-depleted HFKs stained for haematoxylin & Eosin (H&E) and indirect immunofluorescent staining of early [keratins 1 (KRT1), intermediate (transglutaminase-1 (TGM1)] and late [Filaggrin (FLG)] markers of differentiation (scale bar = 100 µM). ( C ) Number of bromodeoxyuridine (BrDU) incorporating cells in organotypic raft culture assessed by immunofluorescent staining. Graph represents the average number of BrDU-positive cells in the basal epithelial layer from organotypic raft cultures per 1000 µM, expressed as percentage scrambled control (mean ± SE at least 10 counts each of two independent biological replicates).

    Article Snippet: The TFAP2A construct was obtained from Addgene [plasmid SP(RSV); 12100) ( )], and matched TFAP2A and TFAP2C image clones in pCMVsport6 were obtained from MRC Geneservice (Cambridge).

    Techniques: Western Blot, Control, Transfection, Generated, Staining